With the digital transformation of the biopharma business in full swing, MedCity INVEST PharmaTech, a digital convention scheduled for July 26, will deliver collectively know-how disruptors, Huge Pharma and biotech leaders, buyers and entrepreneurs to debate learn how to undertake digital methods to remodel each side of the pharma business.
To register, click on right here.
One panel, Pharma + Digital: Right here’s learn how to make it a match made in heaven, will focus on methods for higher alignment and partnerships between the worlds of digital well being and pharma. Panelists embrace:
- Naomi Fried, PhD, CEO and Founder, Pharmstars (moderator)
- Jessica Federer, Accomplice, Boston Millennia Companions
- Joel Krikston, Managing Director Enterprise Investments & Head of Strategic Innovation Alliances, Merck International Well being Innovation Fund
- Jim Parshall, Senior Director — Related Well being & Units Exterior Innovation, Eli Lilly and Firm
Right here’s a take a look at the remainder of the agenda.
The state of AI in drug discovery (on demand)
Synthetic intelligence in healthcare is lastly rising from being overhyped to exhibiting some sensible purposes. If it succeeds within the realms of drug discovery, that might be a monumental achievement serving to each to hurry up and decrease the price for drug improvement. Study from specialists about the place we’re in leveraging AI successfully for drug discovery.
This dialogue might be moderated by MedCity Biopharma Reporter Frank Vinluan.
What Covid taught us about digital scientific trials (on demand)
When going to the hospital – fairly often the location of scientific trials – is not an possibility due to a pandemic, it requires the reimagining of how scientific trials are designed. However can digital, decentralized or site-less scientific trials be as efficient as conventional trials? What are the professionals and cons of working such trials? Hear from specialists within the discipline.
The way forward for digital medicines
Proteus Digital Well being has turn out to be a cautionary story relating to how regardless of enormous curiosity and funding in digital therapeutics and finally regulatory approval, the product by no means gained traction within the market. What are the teachings realized? What’s the panorama of digital medicines right now? Study from specialists within the discipline of pharma, digital well being and commercialization.
The panel discussions will conclude with a startup pitch contest. The theme of this mini Pitch Excellent is reinventing scientific trials.
To use to be a speaker at INVEST PharmaTech, comply with this hyperlink. The deadline to use is Might 26.
For startups interested by pitching within the Pitch Excellent contest, submit your utility right here.
Inquisitive about exploring sponsorship alternatives for INVEST PharmaTech? Please e mail: promoting@medcitynews.com.
Image: Yuuji, Getty Pictures
0 Comments